Correction: Huntington Disease Health Related Quality of Life, Function and Well Being: The Patient's Perspective.

Autor: Pérez-Pérez J; Department of Neurology, Movement Disorders Unit, Hospital de la Santa Creu I Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.; Sant Pau Institute of Biomedical Research (IIB-Sant Pau), Barcelona, Spain.; Centro Investigación Biomedica en Red-Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain., García-López S; Medical Department, Roche Pharma, Madrid, Spain., Valle TF; Department of Neurology, University Hospital Cruces, Neurodegenerative Disease Group Health Research Institute of Bizkaia (BioBizkaia), Neuroscience Department University of the Basque Country, Leioa, Spain., Painous C; Parkinson and Movement Disorders Unit, Neurology Service, Hospital Clínic Universitari, Barcelona, Spain., Querol-Pascual MR; Department of Neurology, Hospital de Badajoz, Badajoz, Spain., Ruiz PJG; Movement Disorders Unit, Department of Neurology, Fundacion Jimenez Diaz, Universidad Autonoma de Madrid, Madrid, Spain., Diago EB; Department of Neurology, Hospital Clínico Universitario Lozano Blesa, Saragossa, Spain.; Research Group of Movement Disorders and Headache (GIIS070), Instituto de Investigación Sanitaria de Aragón (IIS-Aragón), Zaragozaa, Spain., Cubo Delgado E; Hospital Universitario de Burgos, University of Burgos, Burgos, Spain., Pastor BV; Servicio Neurología, Hospital Universitari Son Espases, Palma, Spain., Villaplana MCP; Hospital Universitario La Fe de Valencia, Valencia, Spain., Santana IM; Unidad de Trastornos del Movimiento, Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain., Blázquez Estrada M; Hospital Universitario Central de Asturias, Asturias, Spain., Garride MC; Department of Neurology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain., Mir P; Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain.; Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.; Departamento de Medicina, Facultad de Medicina, Universidad de Sevilla, Seville, Spain., Álvarez C; Medical Department, Roche Pharma, Madrid, Spain., Maurino J; Medical Department, Roche Pharma, Madrid, Spain., de Prado A; Real World Evidence, IQVIA Information S.A, Madrid, Spain., López-Sendón JL; Department of Neurology, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain. jlsendonmoreno@salud.madrid.org.

Publikováno v: Neurology and therapy [Neurol Ther] 2024 Nov 21. Date of Electronic Publication: 2024 Nov 21.

Clinically isolated syndrome: Diagnosis and risk of developing clinically definite multiple sclerosis.

Autor: López-Gómez J; Unidad de Proteínas, Servicio de Análisis Clínicos, Hospital Universitario de Badajoz, Badajoz, Spain. Electronic address: lopezhospi@gmail.com., Sacristán Enciso B; Sección de Proteínas y Autoinmunidad, Servicio de Análisis Clínicos, Hospital de Mérida, Badajoz, Spain., Caro Miró MA; Servicio de Análisis Clínicos, Hospital Universitario de Badajoz, Badajoz, Spain., Querol Pascual MR; Servicio de Neurología, Hospital Universitario de Badajoz, Badajoz, Spain.

Publikováno v: Neurologia [Neurologia (Engl Ed)] 2023 Nov-Dec; Vol. 38 (9), pp. 663-670. Date of Electronic Publication: 2023 Oct 17.

Relationship between sleep quality and cognitive performance in patients with epilepsy.

Autor: Fonseca E; Epilepsy Unit, Neurology Department, Vall d'Hebron University Hospital, Barcelona, Spain; Epilepsy Research Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain; Medicine Department, Universitat Autònoma de Barcelona, Barcelona, Spain., Campos Blanco DM; Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Castro Vilanova MD; Hospital Universitario Álvaro Cunqueiro, Vigo, Spain., Garamendi Í; Cruces University Hospital, Barakaldo, Spain., Gómez-Eguilaz M; Neurology Department, San Pedro Hospital, La Rioja, Spain., Pérez Díaz H; Centro de Neurología Avanzada, Sevilla, Spain., Poza JJ; Hospital Universitario de Donostia, Donostia, Spain., Querol-Pascual MR; Neurology Section, Badajoz University Hospital, Badajoz, Spain., Quiroga-Subirana P; Hospital Universitario Torrecárdenas, Almería, Spain., Rodríguez-Osorio X; Epilepsy Unit, Neurology Service, Hospital Clínico Universitario of Santiago de Compostela, Santiago de Compostela, Spain., Zurita Santamaría J; Hospital Universitario Infanta Leonor, Madrid, Spain., Centeno M; Clínica Universitaria de Navarra, Pamplona, Spain; Hospital Clínic de Barcelona, Barcelona, Spain., Díaz de Cerio Julián L; Neurology Department, Lozano Blesa University Hospital, Aragon Sanitary Research Institute, Zaragoza, Spain., Estévez-María JC; Department of Neurology, University Hospital Reina Sofia, Córdoba, Spain., Martínez Agredano P; Department of Neurology, University Hospital Reina Sofia, Córdoba, Spain., Mauri Llerda JÁ; Neurology Department, Lozano Blesa University Hospital, Aragon Sanitary Research Institute, Zaragoza, Spain., Sala-Padró J; Epilepsy Unit, Hospital Universitari de Bellvitge, Barcelona, Spain., Falip M; Epilepsy Unit, Hospital Universitari de Bellvitge, Barcelona, Spain., Abraira L; Epilepsy Unit, Neurology Department, Vall d'Hebron University Hospital, Barcelona, Spain; Epilepsy Research Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Santamarina E; Epilepsy Unit, Neurology Department, Vall d'Hebron University Hospital, Barcelona, Spain; Epilepsy Research Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Seijo-Raposo I; Epilepsy Unit, Neurology Department, Vall d'Hebron University Hospital, Barcelona, Spain; Epilepsy Research Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Quintana M; Epilepsy Unit, Neurology Department, Vall d'Hebron University Hospital, Barcelona, Spain; Epilepsy Research Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain; Medicine Department, Universitat Autònoma de Barcelona, Barcelona, Spain., Toledo M; Epilepsy Unit, Neurology Department, Vall d'Hebron University Hospital, Barcelona, Spain; Epilepsy Research Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain. Electronic address: mtoledo@vhebron.net.

Publikováno v: Epilepsy & behavior : E&B [Epilepsy Behav] 2021 Sep; Vol. 122, pp. 108127. Date of Electronic Publication: 2021 Jun 17.

Observational multicentre study into the use of antiepileptic drugs in Spanish neurology consultations.

Autor: Mercadé Cerdá JM; Hospital Universitario, Málaga, España. Electronic address: juanmercade@gmail.com., López Gonzalez FJ; Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, A Coruña, España., Serrano Castro P; Hospital Torrecárdenas, Almería, España., Castro Vilanova MD; Hospital Universitario Xeral-Cies, Vigo, Pontevedra, España., Campos Blanco DM; Hospital Clínico Universitario, Valladolid, España., Querol Pascual MR; Hospital Infanta Cristina, Badajoz, España.

Publikováno v: Neurologia (Barcelona, Spain) [Neurologia (Engl Ed)] 2020 Mar; Vol. 35 (2), pp. 115-125. Date of Electronic Publication: 2018 Mar 09.

Disease-modifying therapies as positive predictors of quality of life for Sudanese patients with multiple sclerosis: a cross-sectional study.

Autor: Omar, Eman Saleh¹ (AUTHOR), Suliman, Hayat M.² (AUTHOR), Osman, Bashier² (AUTHOR), Abdalla, Safa A.² (AUTHOR), Abdoon, Iman Hassan² (AUTHOR) imanabdoon@yahoo.com

Publikováno v: Egyptian Journal of Neurology, Psychiatry & Neurosurgery. 6/20/2024, Vol. 60 Issue 1, p1-9. 9p.